COPD clinical trials
137 active trials name this condition (recorded in the registry as “Chronic Obstructive Pulmonary Disease”) . Describe your situation to see which ones you may be eligible for.
Refine by biomarker
By location
- Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD
- A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP)
- Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- Comprehensive Patient-Centered Home-based Care Coaching for COPD Self-management
- Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
- A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Accelerated Pulmonary Rehabilitation in the Preoperative Period
- A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
- A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- The Effect of a Technology-Mediated Integrated Walking and Tai Chi Intervention on Physical Function in Veterans With COPD and Chronic Musculoskeletal Pain
- Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- COPD Resources, Education, and Activity Designed for You Study
- Combined Zephyr Valve System With Inter-lobar Fissure Completion for Lung Volume Reduction in Emphysema
- Effect of Ensifentrine on Sputum Markers of Inflammation in COPD
- Physiologic Effects of Nasal High Flow on Exercise Tolerance in COPD
- Supporting Evidence-based Responses to Emotional Needs in Emphysema
- Evaluation of the Paramedic Evaluation for Acute COPD Exacerbation
- Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF
- A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting Bronchodilators
- Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- A Multi Center Study Testing a New Implant for Adults With Severe Emphysema
- Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia
- An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- PEP Buddy in Pulmonary Rehabilitation
- The Effects of Positive Airway Pressure on the Mucolytic Effects of NAC (TEAM)
- A Study to Evaluate Solrikitug in Participants With COPD (ZION)
- A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
- Inter-lobar Fissure Completion in Patients With Failed Bronchoscopic Lung Volume Reduction
- A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
- Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
- Trial to Determine Effective Aspirin Dose in COPD
- A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
- Right Ventricular Response to Exercise Among Patients With Chronic Obstructive Pulmonary Disease
- Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
- Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention
- The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)
- Feasibility of Semaglutide in Advanced Lung Disease
- Implementation of a Sarcopenia Clinic to Diagnose and Treat Skeletal Muscle Loss Due to COPD
- Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure
- Home Hospital for Suddenly Ill Adults
- Smoking Cessation Pharmacotherapy-Nurse Practitioner Led Tobacco Treatment Team Study
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Chronic Obstructive Pulmonary Disease” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.